Angiopoietin-2 biomarkers predictive of anti-immune checkpoint response

David M. Weinreich, Abraham Antonio Anderson, Predictive biomarker of survival in the treatment of renal cell carcinoma ,(2012)

Gregory P. Winter, Recombinant altered antibodies and methods of making altered antibodies ,(1991)

Martin Eglitis, Jeanne R. McLachlin, W. French Anderson, Michael Blaese, Yawen L. Chiang, Vectors including foreign genes and negative selective markers ,(1992)

Douglas Charles Pfizer Global R D Hanson, Eileen Elliott Pfizer Global R D Mueller, Dennis Alan Pfizer Global R D Noe, Jesus Pfizer Global R D Gomez-Navarro, Uses of anti-ctla-4 antibodies ,(2005)

Xiao-Dong Yang, Larry L. Green, Qing Zhou, David C. Astrazeneca R D Alderley Blakey, Stephen Charles Astrazeneca R D Alderley Emery, Bruce A. Keyt, Antibodies directed to angiopoietin-2 and uses thereof ,(2005)

Michael Alan Boss, Clive Ross Wood, John Henry Kenten, John Spencer Emtage, Multichain polypeptides or proteins and processes for their production ,(1984)

James Blake, Eli Wallace, Hong Woon Yang, Bicyclic inhibitors of mek and methods of use thereof ,(2004)

Daniel Pinkel, Joe W. Gray, Donna Albertson, Comparative fluorescence hybridization to nucleic acid arrays ,(1995)

Cynthia Ann Richards, Brian Huber, Thomas Anthony Krenitsky, Novel entities for cancer therapy ,(1990)

Elaine M. Weidenhammer, Brenda F. Kahl, Ling Wang, Xiao Xu, Michael J. Heller, Methods for gene expression monitoring on electronic microarrays ,(2000)